FDA Drug Application (021330) for COMMIT by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number021330
Product Number001
FormTROCHE/LOZENGE;ORAL
DosageEQ 2MG BASE
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOMMIT
Active IngredientNICOTINE POLACRILEX

Active IngredientCount
List of drugs with Active Ingredient NICOTINE POLACRILEX5


Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS